Abstract |
As well as being expressed as a full-length transcript, the group II metabotropic glutamate receptor 3 (GRM3, mGlu3) gene is expressed as an mRNA isoform which lacks exon 4 (GRM3Δ4) and which is predicted to encode a protein with a novel C terminus (called mGlu3Δ4). This variant may contribute to the mechanism by which GRM3 acts as a schizophrenia risk gene. However, little is known about the properties or function of mGlu3Δ4. Here, using transiently transfected HEK293T/17 cells, we confirm that GRM3Δ4 cDNA is translated, with mGlu3Δ4 existing as a homodimer as well as a monomer, and localizing primarily to cell membranes including the plasma membrane. Co-immunoprecipitation shows that mGlu3Δ4 interacts with canonical mGlu3. mGlu3Δ4 does not bind the mGlu2/3 antagonist [3H] LY341495, but the presence of mGlu3Δ4 reduces binding of [3H] LY341495 to mGlu3, paralleled by a decrease in the abundance of membrane-associated mGlu3. These experiments indicate that mGlu3Δ4 may negatively modulate mGlu3, and thereby impact on the roles of GRM3/mGlu3 in schizophrenia and as a therapeutic target.
|
Authors | Aintzane García-Bea, Isabel Bermudez, Paul J Harrison, Tracy A Lane |
Journal | Journal of psychopharmacology (Oxford, England)
(J Psychopharmacol)
Vol. 31
Issue 12
Pg. 1519-1526
(12 2017)
ISSN: 1461-7285 [Electronic] United States |
PMID | 28655286
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amino Acids
- LY 341495
- Ligands
- Protein Isoforms
- Receptors, Metabotropic Glutamate
- Xanthenes
- metabotropic glutamate receptor 3
- Tritium
|
Topics |
- Amino Acids
(pharmacology)
- Cell Membrane
(metabolism)
- HEK293 Cells
- Humans
- Ligands
- Protein Isoforms
(metabolism)
- Radioligand Assay
- Receptors, Metabotropic Glutamate
(classification, metabolism)
- Schizophrenia
(metabolism)
- Transfection
- Tritium
(metabolism)
- Xanthenes
(pharmacology)
|